“We assessed MMH’s enterprise profile as vulnerable, due in part to a high concentration of inpatient admissions among the top 10 physicians,” said S&P analyst Patrick Zagar.
“Concurrently, we assessed MMH’s financial profile as strong due in part to operating margins and debt service coverage that both compare favorably to similarly rated peers,” he added. “However, we believe the hospital’s financial profile is tempered by light unrestricted reserves, especially when compared to long-term debt. We consider MMH to have a small revenue base, with net patient revenue of $67 million in fiscal 2015.”
The outlook is stable.
More articles on healthcare finance:
Report: ICD-10 conversion minimally impacted hospitals’ cash collections, initial denial rates
This week’s 5 must-reads for hospital CFOs
AccuReg expands reach with new Tennessee office
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
